Spiess Bernhard E. 的 Form 4 申報
Castle Biosciences Inc（CSTL），2021/9/7 申報
- 申報編號
- 0001447362-21-000213
- 申報時間
- 2021/9/7
- 交易日
- 2021/9/2
- 申報延遲
- 5 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 5 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $116.7 萬。交易後 5 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Spiess Bernhard E.CIK 0001782994 | 高階主管（業務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/9/2 | Common Stock | M行使選擇權取得 | +8,989 | $1.92 | +$17,258.88 | 22,551 | 直接 | |
| 2021/9/2 | Common Stock | M行使選擇權取得 | +6,412 | $2.39 | +$15,324.68 | 28,963 | 直接 | |
| 2021/9/2 | Common Stock | S賣出處分 | −8,038 | $75.24F2 | −$604,779.12 | 20,925 | 直接 | |
| 2021/9/2 | Common Stock | S賣出處分 | −5,889 | $76.14F3 | −$448,388.46 | 15,036 | 直接 | |
| 2021/9/2 | Common Stock | S賣出處分 | −1,474 | $77.29F4 | −$113,925.46 | 13,562 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/9/2 | Common Stock | M行使選擇權處分 | −8,989 | $0.00 | $0 | 5,889 | 直接 | |
| 2021/9/2 | Common Stock | M行使選擇權處分 | −6,412 | $0.00 | $0 | 2,304 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $74.59 to $75.58, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $75.60 to $76.45, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $76.70 to $77.63, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。